BSEGeneral10h ago · 4 Nov 2026, 03:19 pm
1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS: The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish Gummadi & Co., Chartered Accountants (Firm Registration No. 023771S), represented by Mr. Harish Gummadi, Partner (Membership No. 232447), resigning from the position of Statutory Auditors of the Company with effect from 03rd November, 2026. 2. APPOINTMENT OF M/S. RANGANATH PRASAD & ....
Transgene Biotek Ltd · 526139
✦ AI SummaryAuditor Change
Transgene Biotek Ltd has announced the resignation of its Statutory Auditors, M/s. Harish Gummadi & Co., due to unforeseen circumstances, and the appointment of M/s. Ranganath Prasad & Co. as their replacement, subject to member approval.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 04Th November, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
64d08e8e-d9c1-4cf3-9cbe-ea65e6a31d13.pdf
View document text
Date: 04-11-2026
The General Manager
Department of Corporate Services – CRD
BSE LIMITED, Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai 400 001.
Dear Sir/Madam,
Sub: Outcome of the Board Meeting held on 04th November, 2026 pursuant to Regulation 30 of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015.
Ref: Scrip Code – BSE: 526139
We wish to inform you that the Board of Directors of Transgene Biotek Limited, at its meeting held on
Wednesday, 04th November, 2026, at 02:30 P.M., inter alia, considered and approved the following matters:
1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS:
The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish
Gummadi & Co., Chartered Accountants (Firm Registration No. 023771S), represented by Mr. Harish
Gummadi, Partner (Membership No. 232447), resigning from the position of Statutory Auditors of the
Company with effect from 03rd November, 2026.
As stated by the outgoing Statutory Auditors in their resignation letter and the accompanying Annexure A,
the resignation was due to unforeseen circumstances arising from a medical emergency in their immediate
family, which affected their professional availability and ability to allocate sufficient time and resources to
undertake and complete the Limited Review of the financial results for the quarter ended 30th September,
2026, within the prescribed timeline.
The Board took note of the reasons stated by the outgoing Statutory Auditors and the information furnished
by them in the prescribed format.
2. APPOINTMENT OF M/S. RANGANATH PRASAD & CO., STATUTORY AUDITORS TO FILL
THE CASUAL VACANCY:
The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment
of M/s Ranganath Prasad & Co., Chartered Accountants (Firm Registration No. 151856W), represented
by Mr. Mocherla Ranganath Prasad (Membership No. 191922), as the Statutory Auditors of the Company to
fill the casual vacancy caused by the resignation of the previous Statutory Auditors, M/s. Harish Gummadi
Plot 69& 70 IDA Bollaram, Sangareddy District – 502 325, Telangana, India
Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com
Email: info@transgenebiotek.com, CIN No: L85195AP1990PLC011065
& Co., Chartered Accountants (Firm Registration No.023771S), represented by Mr. Harish Gummadi,
Partner (Membership No. 232447), pursuant to Section 139(8) of the Companies Act, 2013.
The appointment is subject to the approval of the members of the Company at the ensuing general meeting
to be convened within the prescribed period, in accordance with the applicable provisions of the Companies
Act, 2013. The newly appointed Statutory Auditors shall hold office until the conclusion of the ensuing
Annual General Meeting of the Company.
The Board took note of the consent letter dated 04th November, 2026, the certificate confirming eligibility
for appointment, the Peer Review Certificate (Firm Peer Review No. 027099), and other requisite
declarations and confirmations received from M/s. Ranganath Prasad & Co., Chartered Accountants
(Firm Registration No. 151856W), represented by Mr. Mocherla Ranganath Prasad (Membership No.
191922).
The details pertaining to the appointment, as required under Regulation 30 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, are enclosed herewith as Annexure A.
The Company shall make necessary disclosures in accordance with Regulation 30 of SEBI LODR
Regulations, 2015, read with the applicable SEBI circulars.
The meeting commenced at 02:30 P.M. and concluded at 03:00 P.M.
This intimation is being submitted pursuant to Regulation 30 read with Schedule III of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
Kindly take the above information on record.
Thanking you
Yours Sincerely
For TRANSGENE BIOTEK LIMITED
DR K KOTESWARA RAO
MANAGING DIRECTOR
DIN: 02287235
Enclosure: Annexure – A.
Page 2 of 4
Annexure A
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated January 30, 2026.
S.No Particulars M/s. Harish Gummadi & Co. M/s. Ranganath Prasad & Co.
(Resignation) (Appointment)
1 Reason for change viz. M/s. Harish Gummadi & Co., M/s Ranganath Prasad & Co.,
appointment, re- Chartered Accountants (Firm Chartered Accountants (Firm
appointment, Registration No. 023771S), Registration No. 151856W),
resignation, removal, represented by Mr. Harish represented by Mr. Mocherla
death or otherwise; Gummadi, Partner Ranganath Prasad (Membership No.
(Membership No. 232447), 191922), has been appointed by the
tendered its resignation from Board of Directors, based on the
the position of Statutory recommendation of the Audit
Auditors of the Company, vide Committee, to fill the casual vacancy
its resignation letter dated arising due to the resignation of the
November 03, 2026. previous Statutory Auditors, subject to
the approval of the members of the
The resignation letter, along Company at a general meeting,
with the detailed reasons for pursuant to Section 139(8) of the
resignation provided by the Companies Act, 2013.
Statutory Auditors, is enclosed
herewith.
2 Date of Resignation is effective from Appointed by the Board of Directors
appointment/re- November 03, 2026. on November 04, 2026, subject to the
appointment/cessation approval of the members of the
(as applicable) & term Company at a general meeting to be
of appointment/re- convened within three months from
appointment; the date of the Board's
recommendation. The Statutory
Auditors shall hold office until the
conclusion of the next Annual General
Meeting of the Company, in
accordance with Section 139(8) of the
Companies Act, 2013.
3 Brief profile (in case of Not Applicable M/s Ranganath Prasad & Co.,
appointment); Chartered Accountants, was
established in 2019 and provides
professional services in audit &
Assurance, Bank Audits, Taxation &
Compliance, Internal Controls and
Process Reviews. The firm also
provides assistance in preparation of
project reports, finance proposals,
working capital and banking proposals,
Page 3 of 4
including credit assessment and
sanction applications for various
business sectors, including SMEs,
Furniture, Machine Tools and
Engineering.
4 Disclosure of Not Applicable Not Applicable
relationships between
directors (in case of
appointment of a
director).
Page 4 of 4
INDIA
Harish Gummadi & Co
Chartered Accountants
Date: 03-11-2026
The Board of Directors
M/s Transgene Biotek Limited
Address: 69 & 70 IDA Bollaram,
Sangareddy District - 502 325
Telangana State.
CIN: 1851 95TG1 990P1C01 065
Sub: Resignation as Statutory Auditors of the Company
Dear Sir,
This is to inform you that, due to unforeseen circumstances, we are not in a position
to continue our services as statutory auditors of the Company. Accordingly, we are
submitting our resignation as Statutory Auditors of the Company with effect from
03'd November, 2026. Further, we do not have any objection to appoint any other
statutory auditors in the Company.
We therefore, request you to treat this letter as our resignation from the post of
Statutory Auditors of the Company.
Thanking You
Yours Faithfully,
For & on behalf of
M/s Harish Gummadi & Co
Chartered Accountants
Firm Registration No.: 023771S
Harish Gummadi
Partner
Membership No.:232447
Hyderabad : Flat No. 10 1 , Srikrishna Rali Nilyam, G 'l 34, Madhura Nagar, TG - !999?9
ffi;;;ilr: H. tto. tO-z-sg2, Road No. 2, (otthavaswada, Vidhyanagar, TG - 505001
ANNEXURE A
FORMAT FOR INFORMATION TO BE OBTAINED FROM THE STATUTORY
AUDITOR UPON RESIGNATION
The Board of Directors
M/S. TRANSGENE BIOTEK LIMITED
Address: 69 & 70 IDA Bollaram,
Sangareddy District - 502 325,
Telangana State.
CIN: L85 t 95TG1990PLC01 1065
Subject: Submission of information pursuant to our resignation as Statutory
Auditors of the Company.
Dear
[Showing first 8,000 characters — download PDF for full document]